José C. Garrido

3.6k total citations
10 papers, 433 citations indexed

About

José C. Garrido is a scholar working on Epidemiology, Clinical Biochemistry and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, José C. Garrido has authored 10 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Clinical Biochemistry and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in José C. Garrido's work include Bacterial Identification and Susceptibility Testing (4 papers), Streptococcal Infections and Treatments (3 papers) and Alkaline Phosphatase Research Studies (2 papers). José C. Garrido is often cited by papers focused on Bacterial Identification and Susceptibility Testing (4 papers), Streptococcal Infections and Treatments (3 papers) and Alkaline Phosphatase Research Studies (2 papers). José C. Garrido collaborates with scholars based in Spain and United States. José C. Garrido's co-authors include Galo Peralta, María Pía Roiz Mesones, Inés de Benito, M.E. Cano, Luis Martínez‐Martínez, María Blanca Sánchez, J.A. Amado, José M. Olmos, José Luis Pérez‐Castrillón and Jesús González-Macı́as and has published in prestigious journals such as Clinical Chemistry, Journal of Antimicrobial Chemotherapy and Clinical Microbiology and Infection.

In The Last Decade

José C. Garrido

10 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
José C. Garrido Spain 9 174 169 105 86 69 10 433
Ramón Pérez-Cano Spain 10 350 2.0× 68 0.4× 446 4.2× 21 0.2× 140 2.0× 15 803
Hiroki Fujimoto Japan 12 144 0.8× 181 1.1× 52 0.5× 21 0.2× 29 0.4× 25 476
Andrea Berlingeri Italy 9 103 0.6× 60 0.4× 284 2.7× 22 0.3× 69 1.0× 14 431
Mats Bue Denmark 16 127 0.7× 99 0.6× 42 0.4× 28 0.3× 25 0.4× 74 698
Partha Bagchi United States 8 118 0.7× 93 0.6× 85 0.8× 85 1.0× 19 0.3× 10 402
Žilvinas Endzinas Lithuania 9 65 0.4× 135 0.8× 49 0.5× 90 1.0× 28 0.4× 24 480
A Marton Hungary 7 489 2.8× 32 0.2× 125 1.2× 110 1.3× 47 0.7× 17 619
Inés de Benito Spain 6 136 0.8× 131 0.8× 93 0.9× 63 0.7× 63 0.9× 8 284
Mayra Matesanz Spain 9 169 1.0× 38 0.2× 44 0.4× 83 1.0× 25 0.4× 21 300
Gauthier Péan de Ponfilly France 10 121 0.7× 98 0.6× 68 0.6× 43 0.5× 39 0.6× 32 288

Countries citing papers authored by José C. Garrido

Since Specialization
Citations

This map shows the geographic impact of José C. Garrido's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José C. Garrido with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José C. Garrido more than expected).

Fields of papers citing papers by José C. Garrido

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José C. Garrido. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José C. Garrido. The network helps show where José C. Garrido may publish in the future.

Co-authorship network of co-authors of José C. Garrido

This figure shows the co-authorship network connecting the top 25 collaborators of José C. Garrido. A scholar is included among the top collaborators of José C. Garrido based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José C. Garrido. José C. Garrido is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Peralta, Galo, et al.. (2010). Altered blood glucose concentration is associated with risk of death among patients with community-acquired Gram-negative rod bacteremia. BMC Infectious Diseases. 10(1). 181–181. 11 indexed citations
2.
Peralta, Galo, et al.. (2009). Diabetes does not affect outcome in patients with Enterobacteriaceae bacteremia. BMC Infectious Diseases. 9(1). 94–94. 17 indexed citations
3.
Peralta, Galo, et al.. (2007). Time-to-positivity in patients with Escherichia coli bacteraemia. Clinical Microbiology and Infection. 13(11). 1077–1082. 46 indexed citations
4.
Peralta, Galo, José C. Garrido, Inés de Benito, et al.. (2007). Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. Journal of Antimicrobial Chemotherapy. 60(4). 855–863. 145 indexed citations
5.
Peralta, Galo, Eric Padron, María Pía Roiz Mesones, et al.. (2006). Risk factors for bacteremia in patients with limb cellulitis. European Journal of Clinical Microbiology & Infectious Diseases. 25(10). 619–626. 41 indexed citations
6.
Peralta, Galo, et al.. (2006). Time to positivity in blood cultures of adults with Streptococcus pneumoniaebacteremia. BMC Infectious Diseases. 6(1). 79–79. 56 indexed citations
7.
Ramı́rez, José Luis, Rafael Torronteras, Justo P. Castaño, et al.. (1997). Somatostatin Plays a Dual, Stimulatory/Inhibitory Role in the Control of Growth Hormone Secretion by Two Somatotrope Subpopulations from Porcine Pituitary. Journal of Neuroendocrinology. 9(11). 841–848. 28 indexed citations
8.
Olmos, José M., et al.. (1994). Bone densitometry and biochemical bone remodeling markers in type 1 diabetes mellitus. Bone and Mineral. 26(1). 1–8. 77 indexed citations
9.
Garrido, José C., et al.. (1992). Comparison of Three Bone Alkaline Phosphatase Quantification Methods in Patients with Increased Alkaline Phosphatase Activities. Clinical Chemistry. 38(6). 1165–1166. 10 indexed citations
10.
Aguayo, Francisco, et al.. (1992). Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: Effect of Corticosteroids and Azathioprine. European Neurology. 32(6). 349–353. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026